Skip to Content

Droperidol Disease Interactions

There are 4 disease interactions with droperidol:

Major

Droperidol (applies to droperidol) cardiovascular

Major Potential Hazard, Moderate plausibility. Applicable conditions: Long QT Syndrome, Electrolyte Abnormalities, Hypokalemia, Magnesium Imbalance

Cases of QT prolongation and/or torsade de pointes have been reported in patients receiving droperidol at doses at or below recommended doses. Extreme caution is recommended when using this agent in patients with risk factors for development of prolonged QT syndrome, such as clinically significant bradycardia, any clinically significant cardiac disease, treatment with Class I and Class III antiarrhythmics, treatment with monoamine oxidase inhibitors (MAOI's), concomitant treatment with other drug products known to prolong the QT interval, and electrolyte imbalance, in particular hypokalemia and hypomagnesemia, or concomitant treatment with drugs that may cause electrolyte imbalance. It is advisable that all patients undergo a 12-lead ECG prior to administration to determine if a prolonged QT interval (i.e., QTc greater than 440 msec. for males or 450 msec. for females) is present. If there is a prolonged QT interval, droperidol should not be administered.

Major

Droperidol (applies to droperidol) QT prolongation

Major Potential Hazard, Moderate plausibility. Applicable conditions: Long QT Syndrome

The use of droperidol is contraindicated in patients with known or suspected QT prolongation (i.e., QTc interval greater than 440 msec. for males or 450 msec. for females), including those patients with congenital long QT syndrome.

Moderate

Droperidol (applies to droperidol) hepatic/renal dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Droperidol should be administered with caution in patients with liver and kidney dysfunction because of the importance of these organs in the metabolism and excretion of drugs.

Moderate

Droperidol (applies to droperidol) pheochromocytoma

Moderate Potential Hazard, Moderate plausibility.

Droperidol should be used with caution in patients with diagnosed or suspected pheochromocytoma as severe hypertension and tachycardia have been observed after its administration.

Droperidol drug interactions

There are 489 drug interactions with droperidol

Droperidol alcohol/food interactions

There is 1 alcohol/food interaction with droperidol

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.